Nathalie Strub‐Wourgaft
Université Paris-Panthéon-Assas(FR)Drugs for Neglected Diseases Initiative(CH)Panthera Corporation(US)Office of Readiness and Response(US)Unitaid(CH)Université Paris 1 Panthéon-Sorbonne(FR)
Publications by Year
Research Areas
Research on Leishmaniasis Studies, Trypanosoma species research and implications, SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, Long-Term Effects of COVID-19
Most-Cited Works
- → The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment(2013)346 cited
- → Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial(2011)335 cited
- → Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial(2018)292 cited
- → Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial(2017)267 cited
- → Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives(2018)214 cited
- → New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial